Dr. Eric K. Singhi discusses the significance of the FDA approval of subcutaneous Opdivo for patients with solid tumors.

Maintaining good eyesight is more critical than ever in today's fast-paced world. With rising screen time and environmental ...

Few fields in medicine are as promising and complex as gene therapy. As researchers race to develop cures for previously ...

The agency wants applicants to demystify their algorithms and provide specific details about what the models do, how they’re ...

Alyea Therapeutics to Present at Biotech Showcase 2025 During 43rd Annual J.P. Morgan Healthcare Conference Week ...

Already approved for smoking and treatment-resistant depression, brain stimulation is being tested for multiple addictions ...

A new study questioned the clinical utility of an algorithm meant to predict opioid use disorder (OUD) risk based on 15 ...

Stay updated on the latest potential FDA drug approvals in 2025, including an expanded label for Ozempic and new, nonopioid painkillers.

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.

Opioid misuse and specifically opioid use disorder (OUD), continues to represent a significant U.S. public health threat, ...

An Interview with Innocan Pharma’s CEO, Iris Bincovich. Innocan Pharma is gaining attention for its innovative pain relief ...

Lupin receives US FDA tentative approval for loteprednol etabonate ophthalmic gel: Our Bureau, Mumbai Thursday, January 9, 2025, 17:20 Hrs [IST] Global pharma major Lupin Limited ...